Dr. Ivan Puah developed MDC-Sculpt(R) Lipo technique to achieve optimal liposuction results in patients
SINGAPORE, Nov. 11, 2021 /PRNewswire/ -- Dr Ivan Puah, Medical Director at Amaris B. Clinic, who has been performing liposuction, correction surgery and gynecomastia surgery for more than 15 years, has developed a liposuction technique called MDC-Sculpt®️ Lipo technique. This proprietary approach is to achieve the three main objectives of successful and optimal contouring results for patients –...
CNN’s ‘Tech for Good’ explores the world of fitness technology
HONG KONG, Nov. 11, 2021 /PRNewswire/ -- For many, the pandemic has resulted in a shift to a more sedentary lifestyle, raising alarm bells for health experts. On the latest episode of 'Tech for Good', CNN anchor and correspondent Kristie Lu Stout meets the minds behind the technologies that are aimed at combating this trend. From virtual reality gyms to...
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-negative Breast Cancer Meets Primary Overall Response Rate Endpoint
SHANGHAI, Nov. 11, 2021 /PRNewswire/ -- Everest Medicines and Gilead Sciences, Inc. (Nasdaq: GILD) jointly announces today that Everest Medicines' (HKEX 1952.HK) Phase 2b EVER-132-001 study of sacituzumab govitecan (marketed as Trodelvy® in the United States) met its primary endpoint of overall response rate (ORR) in metastatic triple-negative breast cancer (TNBC). EVER-132-001 is a single-arm, multi-center Phase 2b registrational study...
New EZZ genomic products attract strong Chinese interest at CIIE 2021
SYDNEY, Nov. 11, 2021 /PRNewswire/ -- From November 5 to 10, the 4th China International Import Expo took place in Shanghai, with a focus on global high-tech companies. EZZ Life Science Holdings Limited (ASX: EZZ), a leading company in life sciences in Australia, was invited to participate for the first time, delivering access to Chinese investors and consumers, who attended...
Luye Pharma Grants Zambon Exclusive Commercialization Rights to Its Innovative Alzheimer’s Disease Treatment Rivastigmine Multi-Day Transdermal Patch in Switzerland
BASEL, Switzerland, Nov. 10, 2021 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into an agreement with Zambon Switzerland (Zambon), under which the company grants Zambon exclusive rights to commercialize Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) in Switzerland. Rivastigmine MD is a twice-weekly innovative patch formulation of Rivastigmine for the treatment of mild...
Recruitment for the dosimetry phase of Clarity’s Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial completed
Clarity Pharmaceuticals completes recruitment for the initial dosimetry phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604) investigating Targeted Copper Theranostics (TCT) in patients with metastatic castrate-resistant prostate cancer (mCRPC). Dosimetry data is being prepared for Safety Review Committee before moving into therapeutic applications with 67Cu SAR-bisPSMA therapy. Clarity shares preliminary imaging results from the dosimetry...
Hill’s Pet Nutrition Partners With Bond Pet Foods, Inc. To Develop A Craft Meat Protein Produced Through Precision Fermentation
New Agreement to Explore Sustainable Meat Protein to Provide Long-Term Options for Cat and Dog Nutrition TOPEKA, Kan. and BOULDER, Colo., Nov. 10, 2021 /PRNewswire/ -- Hill's Pet Nutrition, a global leader in biology-based pet nutrition, and Bond Pet Foods, Inc., the Boulder-based leader in creating meat proteins via fermentation for pet food...
IASO Biotherapeutics and Innovent Biologics to Present New BCMA CAR-T Cell Therapy Data in Oral Presentation at ASH 2021
SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 10, 2021 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative medicines, today announced that the updated data from Phase1/2 study of CT103A, a fully human B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy...
Care Group Acquires Pukekohe Family Health Care to Become Largest Provider of Primary Care in East Auckland
AUCKLAND, New Zealand, Nov. 10, 2021 /PRNewswire/ -- Care Group, a renowned provider and integrator of health services, has acquired Pukekohe Family Health Care (PFHC), a large general practice based in Central Pukekohe. The latest acquisition is in sync with the group's vision to build community health in Auckland. The Pukekohe Family Health Care will be a part of...
David C. Dvorak is THINK Surgical’s New Executive Chairman of the Board of Directors
FREMONT, Calif., Nov. 10, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of David C. Dvorak as the Executive Chairman of its Board of Directors. Mr. Dvorak's decades of experience in the medical device industry, particularly in the orthopedics industry and enabling technologies for orthopedic surgery, makes him...
